vida: extract claims from 2026-04-29-price-transparency-limited-insured-market-impact-2025

- Source: inbox/queue/2026-04-29-price-transparency-limited-insured-market-impact-2025.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/hospital-price-transparency-produces-cost-reductions-only-for-self-pay-elective-procedures-not-insured-patients.md

@@ -11,7 +11,7 @@ sourced_from: health/2026-04-29-price-transparency-limited-insured-market-impact
 scope: structural
 sourcer: "Multiple sources: Mathematica, SAGE Journals, Brookings, CMS"
 supports: ["proxy-inertia-is-the-most-reliable-predictor-of-incumbent-failure-because-current-profitability-rationally-discourages-pursuit-of-viable-futures"]
-related: ["value-based-care-transitions-stall-at-the-payment-boundary-because-60-percent-of-payments-touch-value-metrics-but-only-14-percent-bear-full-risk", "proxy-inertia-is-the-most-reliable-predictor-of-incumbent-failure-because-current-profitability-rationally-discourages-pursuit-of-viable-futures"]
+related: ["value-based-care-transitions-stall-at-the-payment-boundary-because-60-percent-of-payments-touch-value-metrics-but-only-14-percent-bear-full-risk", "proxy-inertia-is-the-most-reliable-predictor-of-incumbent-failure-because-current-profitability-rationally-discourages-pursuit-of-viable-futures", "hospital-price-transparency-produces-cost-reductions-only-for-self-pay-elective-procedures-not-insured-patients"]
 ---
 
 # Hospital price transparency rules produce measurable cost reductions only for self-pay patients seeking elective procedures while insured patients show no behavioral change because insurance insulates them from marginal cost
@@ -24,3 +24,10 @@ Multiple 2025 studies show hospital price transparency compliance remains poor (
 **Source:** MedCity News context, March 2026
 
 Broader research cited in source shows hospital price transparency rules have limited impact on insured patients, with consumer price pressure limited to self-pay elective procedures only. Insured patients (the majority) show no behavioral changes from price transparency, paralleling the DTE pricing story where headline list price cuts don't translate to net price reductions for insured populations.
+
+
+## Supporting Evidence
+
+**Source:** Pan & Yaraghi SAGE 2025, CMS compliance data 2025
+
+Pan & Yaraghi SAGE 2025 study confirms price transparency does NOT broadly reduce hospital charges and behavioral changes were NOT observed for insured patients. Only self-pay patients opting for elective procedures showed lower charges. 55% of 3,558 Medicare-certified hospitals had not posted readable commercial negotiated price files 6 months after rule took effect, demonstrating active institutional resistance. Insured patients are insulated from full cost through copay/deductible structure and have limited provider choice through network restrictions, making them structurally unresponsive to price signals regardless of transparency.

inbox/archive/health/2026-04-29-price-transparency-limited-insured-market-impact-2025.md

@@ -56,7 +56,7 @@ Aggregated from multiple 2025 sources on hospital price transparency compliance
 **KB connections:**
 - Confirms [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] — hospitals are resisting transparency
 - Supports Belief 3: market mechanisms (price transparency) don't restructure FFS incentives
-- Connects to [[optimization for efficiency without regard for resilience creates systemic fragility...]] — the FFS system optimizes against the mechanisms intended to discipline it
+- Connects to optimization for efficiency without regard for resilience creates systemic fragility... — the FFS system optimizes against the mechanisms intended to discipline it
 
 **Extraction hints:**
 - CLAIM: "Hospital price transparency rules produce measurable cost reductions only for self-pay patients seeking elective procedures — insured patients (the majority) show no behavioral change because insurance insulates them from marginal cost, leaving the FFS payment structure that determines provider incentives unchanged"

inbox/queue/2026-04-29-price-transparency-limited-insured-market-impact-2025.md

@@ -1,69 +0,0 @@
----
-type: source
-title: "Hospital Price Transparency 2025: Limited Market Impact for Insured Patients, Selective Effect for Self-Pay Elective Procedures"
-author: "Multiple sources: Mathematica, SAGE Journals, Brookings, CMS"
-url: https://journals.sagepub.com/doi/10.1177/10591478251367520
-date: 2025-01-01
-domain: health
-secondary_domains: []
-format: research
-status: unprocessed
-priority: medium
-tags: [price-transparency, market-competition, healthcare-costs, consumer-behavior, structural-reform]
-intake_tier: research-task
----
-
-## Content
-
-Aggregated from multiple 2025 sources on hospital price transparency compliance and market impact:
-
-**Compliance status (2025):**
-- 55% of 3,558 Medicare-certified general acute care hospitals had NOT posted readable commercial negotiated price files 6 months after rule took effect
-- 2025: additional requirements to publish estimated actual payment (allowed) amounts
-- Trump executive order February 25, 2025: new requirements for price transparency within 90 days
-
-**Market impact on consumer behavior (Pan & Yaraghi, SAGE 2025):**
-- Does NOT broadly reduce hospital charges
-- DOES lead to lower charges for self-pay patients opting for elective procedures who are sensitive to price and can shop
-- "Behavioral changes were NOT observed for insured patients"
-- Reason: insured patients insulated from full cost; less flexibility in provider choice
-
-**Theoretical upside (Brookings):**
-- Using 40% reduction in "shoppable" service expenditures: potential impact as high as $80.1 billion for commercial population
-- But this assumes significant behavioral change that hasn't materialized for insured patients
-
-**Why insured patients don't respond:**
-- Insured patients typically owe copay/deductible, not full price — price transparency doesn't change their marginal cost
-- Provider networks (HMO, narrow network plans) limit patient choice regardless of price knowledge
-- Emergency care, specialist referrals, surgery — not "shoppable" in the consumer sense
-
-**Context — Belief 3 implications:**
-- Market competition via price transparency is structurally limited to self-pay, elective, "shoppable" care — a minority of total healthcare spending
-- The majority of healthcare spending (insurance-mediated, emergency, specialist, inpatient) is structurally non-competitive regardless of price disclosure
-- FFS payment incentives operate at the payer-provider level, not the consumer level — price transparency doesn't touch this layer
-
-## Agent Notes
-
-**Why this matters:** Tests the "market competition bypasses structural misalignment" counter-argument to Belief 3. Price transparency is the most cited mechanism for consumer-driven healthcare cost reduction. The evidence: limited to self-pay elective procedures. The majority of healthcare spending is structurally insulated from consumer price pressure.
-
-**What surprised me:** The 55% hospital non-compliance rate even in 2025, years after the rule. Hospitals are actively resisting transparency despite the legal mandate. This is the proxy inertia prediction playing out in real time — financially successful institutions are not voluntarily enabling competitive pressure.
-
-**What I expected but didn't find:** Any evidence that transparency rules are producing systematic price competition between hospitals. Even where data is available, the evidence shows no broad charge reduction for insured patients.
-
-**KB connections:**
-- Confirms [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]] — hospitals are resisting transparency
-- Supports Belief 3: market mechanisms (price transparency) don't restructure FFS incentives
-- Connects to optimization for efficiency without regard for resilience creates systemic fragility... — the FFS system optimizes against the mechanisms intended to discipline it
-
-**Extraction hints:**
-- CLAIM: "Hospital price transparency rules produce measurable cost reductions only for self-pay patients seeking elective procedures — insured patients (the majority) show no behavioral change because insurance insulates them from marginal cost, leaving the FFS payment structure that determines provider incentives unchanged"
-- This is a scope-qualified claim about where market competition WORKS (self-pay elective) vs. where it DOESN'T (the majority of spending)
-- Confidence level: likely (confirmed by multiple independent studies)
-
-**Context:** Multiple 2025 sources synthesized. The Brookings piece is broadly cited. The Pan & Yaraghi SAGE paper is the most rigorous empirical analysis. CMS requirements still evolving.
-
-## Curator Notes
-
-PRIMARY CONNECTION: [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]]
-WHY ARCHIVED: Documents the limits of market competition as structural bypass for healthcare misalignment — price transparency doesn't touch FFS payment incentives, and insured patients (majority) don't respond to price signals. Directly relevant to Belief 3 disconfirmation attempt.
-EXTRACTION HINT: Focus on the scope qualification: transparency works for self-pay elective procedures only. Insured care (the majority) is structurally insulated. This makes market competition a marginal mechanism, not a structural bypass.